Wait times represent the average estimated length of time from registration to being assigned a "first provider" (a doctor, nurse practitioner or physician assistant). Times displayed for Atlantic Health Systems are:

  • Reported as an average of wait times for the previous 2 hours of patients that have presented to the emergency department and have been seen by a provider
  • Refreshed at least every 15 minutes

Many circumstances can affect wait times - for example, patients arriving by ambulance or with life-threatening injuries or illnesses. Patients with severe conditions will be seen before those with less-serious problems or ailments. These times are provided for informational purposes only and cannot be guaranteed upon arrival.

Location Emergency Wait

Last Updated: Aug. 28, 2017 10:36 am

Emergency? Call 911!

Classes & Events eNews Feedback Donate

Accelerated Breast Radiation

Standard breast radiotherapy is provided daily for as long as five to seven weeks. This can be a difficult time commitment for patients with busy schedules. That’s why, when appropriate, Atlantic Health System Cancer Care provides eligible patients with a more convenient and cost-effective option called accelerated breast radiation.

This technique, also known as hypofractionated radiation or Canadian fractionation, shortens the overall length of therapy to approximately three weeks, while maintaining positive results, both in terms of cancer control and cosmetic appearance. Patients receive greater doses of radiation on a daily basis, but the overall dosage at the completion of treatment remains the same when compared to standard radiotherapy.

In addition, some physicians may provide accelerated breast radiation to patients in the prone position (lying face down), which reduces radiation exposure to the skin and nearby vital organs, such as the heart and lungs.

Both the National Comprehensive Cancer Network (NCCN) and the American Society for Radiation Oncology (ASTRO) have endorsed accelerated breast radiation as an acceptable course of treatment for eligible women – those with node-free, early stage breast cancer who have not yet received chemotherapy.